Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to learn about the safety and effectiveness of pulmonary artery banding(PAB) therapy in pediatric heart failure(PHF) patients. The main questions it aims to answer are: - Can PAB therapy improve left ventricular(LV) function in PHF patients especially refractory PHF. - Can the complications caused by the PAB therapy be clinically acceptable? Participants underwent PAB therapy will be required to underwent echocardiography, electrocardiograms, complete blood counts, biochemical tests, and measurements of N-terminal pro-brain natriuretic peptide (NT-proBNP) follow-up before the initiation of PAB and at 1 month, 3 months, and 6 months after PAB surgery. Researchers will compare the LV function 6 months after PAB suergey and the preoperative ones to see if there is improvement.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06039553
Study type Observational [Patient Registry]
Source China National Center for Cardiovascular Diseases
Contact Kai Ma, PhD
Phone +86 15901428497
Email drmakaifw@yahoo.com
Status Recruiting
Phase
Start date January 1, 2022
Completion date December 31, 2024